Bluejay Diagnostics, Inc.
BJDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $786 | $890 | $785 | $554 |
| G&A Expenses | $831 | $1,095 | $1,104 | $930 |
| SG&A Expenses | $831 | $1,095 | $1,104 | $931 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $1,617 | $1,985 | $1,889 | $1,485 |
| Operating Income | -$1,617 | -$1,985 | -$1,889 | -$1,485 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $19 | $29 | $24 | $53 |
| Pre-Tax Income | -$1,598 | -$1,957 | -$1,864 | -$1,432 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,598 | -$1,957 | -$1,864 | -$1,432 |
| % Margin | – | – | – | – |
| EPS | -1.01 | -1.41 | -11.64 | -8.94 |
| % Growth | 28.4% | 87.9% | -30.2% | – |
| EPS Diluted | -1.01 | -1.41 | -11.64 | -8.94 |
| Weighted Avg Shares Out | 1,575 | 1,387 | 160 | 160 |
| Weighted Avg Shares Out Dil | 1,575 | 1,387 | 160 | 160 |
| Supplemental Information | – | – | – | – |
| Interest Income | $19 | $29 | $18 | $146 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $11 | $38 | $52 | $37 |
| EBITDA | -$1,587 | -$1,918 | -$1,837 | -$1,394 |
| % Margin | – | – | – | – |